DNA X, Inc. - 8-K Filing
DNA X, Inc. approves substitute cash grant for acting CEO Mike Mulica due to lack of available equity under 2019 Equity Incentive Plan.
Tickers: $SONM
DNA X, Inc. approves substitute cash grant for acting CEO Mike Mulica due to lack of available equity under 2019 Equity Incentive Plan.
Tickers: $SONM